Myomo (MYO) Receivables - Other (2016 - 2021)

Myomo's (MYO) quarterly Receivables - Other came in at $25900.0 in Q1 2021, down 42.32% on a QoQ basis from $44900.0 in Q4 2020.

Myomo (MYO) Receivables - Other (2016 - 2021) Analysis & Trends

Myomo (MYO) has 6 years of Receivables - Other data on file, last reported at $25900.0 in Q1 2021.

Quarterly Receivables - Other changed N/A year-over-year to $25900.0 in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $25900.0 (changed N/A YoY) and the FY2020 annual result came in at $44900.0, up 73.36% from the prior year.
Receivables - Other retreated to $25900.0 in Q1 2021, from $44900.0 in the prior quarter.
In the past five years, Receivables - Other ranged from a high of $155000.0 in Q2 2018 to a low of $19000.0 in Q3 2020.
A 5-year average of $50360.0 and a median of $35400.0 in 2019 frame the typical range for Receivables - Other.
Annual changes were most pronounced in 2017 — Receivables - Other jumped 216.73% — and 2019, when it sank 49.9%.
Tracing MYO's Receivables - Other over 5 years: stood at $77600.0 in 2017, then plunged by 33.25% to $51800.0 in 2018, then slumped by 50.0% to $25900.0 in 2019, then soared by 73.36% to $44900.0 in 2020, then plunged by 42.32% to $25900.0 in 2021.
The last three Receivables - Other figures came in at $25900.0 (Q1 2021), $44900.0 (Q4 2020), and $19000.0 (Q3 2020), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn
10	Myomo	67.26 Mn	48.29 Mn	-

Download Data